Clinical Trial Update: A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease [Phase 2]

View source ↗

Summary

Phase II study in patients with moderate to severe active Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: Reistone Biopharma Company Limited | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED